he Institute of Vaccines and Medical Biologicals (IVAC) of Vietnam has announced the successful production of inactivated seasonal influenza vaccine (IVACFLU-S) for commercial use.
In 2018, the Ministry of Health (MoH) will use three new vaccines for the national expanded vaccination programme (NEVP). The India-made Combe Five will replace Quinvaxem vaccine in the NEVP.
Vietnam will use three new vaccines in the national expanded vaccination programme (NEVP) this year, heard a workshop held by the Ministry of Health (MoH) on April 16.
Public health organisations from member countries of the Association of Southeast Asian Nations (ASEAN) and the globe have pooled their efforts for the development of needed vaccines for the region.
The Ministry of Agriculture and Rural Development expects the mass production of the first made-in-Vietnam vaccines against foot-and-mouth disease will start in the second quarter of 2018.
Next year, Vietnam expects to produce and provide a sufficient supply of vaccines against foot-and-mouth disease, an infectious and sometime fatal viral disease that affects cloven-hoofed animals, including cattle and pigs, as heard at a conference in Hanoi on December 18.
Health care officials from 63 localities nationwide gathered at a conference in Bac Giang city of the northern province of Bac Giang on September 26 to discuss measures to control and erase rabies in Vietnam.
Up to present, 12 products have received Government approval to be put in the list of national products under the National Product Development Programme to 2020.
Immunisation work has made significant contributions to protecting and improving health of Vietnamese children and the public, realising Millennium Development Goals.
The Vietnamese Government should intervene to reduce the rate of caesarean section deliveries, which has been rising in the country, an international expert has said.
Vietnam is expected to produce six-in-one vaccines in 2017 or 2018 and by 2020 these will be used widely in the country, according to the Ministry of Health.
Vaccines against pneumonia, diarrhoea and the HPV virus that causes cervical cancer will be added to the national immunisation programme, with support from the Global Alliance for Vaccines and Immunis